Answers are grounded in this paper and cite their sources.
Prospective comparative study demonstrates reduced scan length and radiation dose in pancreatic CT, indicating enhanced targeting without compromising organ depiction.
Background/Objectives: The ultra-high-resolution (UHR) mode of photon-counting detector computed tomography (PCD-CT) is the most dose-intensive series of a multiphase pancreatic protocol in relation to its scan length, and the pancreas cannot be localised on a topogram. We assessed whether an ultra-low-dose (ULD) unenhanced planning series reduces its scan range and dose without compromising complete depiction of the pancreas. Methods: In this prospective single-centre study, 61 pancreatic protocol examinations in 56 patients were performed on a first-generation dual-source PCD-CT. Following a protocol change, the UHR scan range was planned from the topogram in group A (n = 30) and from a ULD unenhanced series in group B (n = 31). Dose indices, scan length, margins to the pancreas and completeness of depiction were recorded. Results: The UHR scan range was 27% shorter in group B (114 vs. 160 mm; p < 0.001), driven by the cranial margin (−58%; p < 0.001) rather than the caudal margin (p = 0.076). Neither the volume CT dose index nor the size-specific dose estimate of the UHR series differed (p = 0.74 and p = 0.35), yet its dose–length product fell by 25% (p = 0.003) and its share of the dose excluding the mandatory venous phase fell from 62.0% to 50.7% (p < 0.001). The total dose was 7.5% lower without reaching significance (p = 0.37). Incomplete depiction occurred in 5 of 30 vs. 5 of 31 examinations (p = 1.00). The body habitus was closely matched. Conclusions: A ULD planning series was associated with a more tightly targeted UHR pancreatic phase, with a 27% shorter scan range and a 25% lower dose–length product for that series, and with no detected increase in incomplete depiction of the pancreas. With topogram-based planning alone, over-scanning was most pronounced at the cranial border. The reduction was confined to the ultra-high-resolution series and was statistically significant there; the total examination dose was lower with ultra-low-dose planning, but this difference was not statistically significant and no conclusion about total dose should be drawn from it.
No takes yet. Share an insight, caveat, or question.
Arnoldner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: